BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28188488)

  • 21. Identification of long non-coding RNA
    Luo P; Liang C; Zhang X; Liu X; Wang Y; Wu M; Feng X; Tu J
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29559565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Exosomal Long Noncoding RNAs
    Xu H; Chen Y; Dong X; Wang X
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):710-716. PubMed ID: 29650788
    [No Abstract]   [Full Text] [Related]  

  • 23. Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma.
    Yuan W; Sun Y; Liu L; Zhou B; Wang S; Gu D
    Cell Physiol Biochem; 2017; 44(1):125-132. PubMed ID: 29130980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of diagnostic long non‑coding RNA biomarkers in patients with hepatocellular carcinoma.
    Li G; Shi H; Wang X; Wang B; Qu Q; Geng H; Sun H
    Mol Med Rep; 2019 Aug; 20(2):1121-1130. PubMed ID: 31173205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma.
    Han Y; Jiang W; Wang Y; Zhao M; Li Y; Ren L
    BMC Cancer; 2022 Apr; 22(1):431. PubMed ID: 35443674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormally Expressed Circular RNAs are Promising Biomarkers for Diagnosis of Hepatocellular Carcinoma: a Meta-Analysis.
    Yu G; Yang L; Zhou J; Zhang L; Xia L
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis.
    Liao Q; Han P; Huang Y; Wu Z; Chen Q; Li S; Ye J; Wu X
    PLoS One; 2015; 10(6):e0130677. PubMed ID: 26114756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
    Ma Y; Luo T; Dong D; Wu X; Wang Y
    Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Wang J; Pu J; Yao T; Lu X; Deng Y
    J Cell Physiol; 2019 Jun; 234(6):8709-8716. PubMed ID: 30417366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA sequencing identifies two novel liver-specific long noncoding RNAs with potential diagnostic value in hepatocellular carcinoma.
    Tan C; Zeng X; Mo M; Ma X; Liang Q; Liang W; Huang W; Wang K; Yang L; Qiu X
    Biomark Med; 2021 Sep; 15(13):1097-1109. PubMed ID: 34128691
    [No Abstract]   [Full Text] [Related]  

  • 32. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Long Noncoding RNAs,
    Qin Y; Tu X; Huang M; Ma C; Huang Q; Huang Q; Shu H; Ou C
    DNA Cell Biol; 2023 Aug; 42(8):488-497. PubMed ID: 37527208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A four-long noncoding RNA signature predicts survival of hepatocellular carcinoma patients.
    Jiang H; Zhao L; Chen Y; Sun L
    J Clin Lab Anal; 2020 Sep; 34(9):e23377. PubMed ID: 32474975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of prognostic biomarkers of hepatocellular carcinoma via long noncoding RNA expression and copy number alterations.
    Du W; Chen W; Shu Z; Xiang D; Bi K; Lu Y; Zhang X; Li L; Diao H
    Epigenomics; 2020 Aug; 12(15):1303-1315. PubMed ID: 32772564
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma.
    Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q
    Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential lncRNA Biomarkers for HBV-Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network.
    Nong S; Chen X; Wang Z; Xu G; Wei W; Peng B; Zhou L; Wei L; Zhao J; Wei Q; Deng Y; Meng L
    Biomed Res Int; 2021; 2021():9972011. PubMed ID: 34692847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
    Jia X; Liu J; Gao Y; Huang Y; Du Z
    Arch Med Res; 2014 Oct; 45(7):580-8. PubMed ID: 25446613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.
    Kamel MM; Matboli M; Sallam M; Montasser IF; Saad AS; El-Tawdi AHF
    Transl Res; 2016 Feb; 168():134-145. PubMed ID: 26551349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.